| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $24.8M | -38.8% |
| SG&A Expense | $13.3M | -5.2% |
| Operating Income | -$38.1M | +32.9% |
| Income Tax | $0 | — |
| Net Income | -$35.2M | +31.5% |
| EPS (Basic) | -$1.16 | +32.6% |
| EPS (Diluted) | -$1.16 | +32.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.9M | -6.6% |
| Current Assets | $59.9M | -30.5% |
| Total Assets | $62.0M | -32.7% |
| Current Liabilities | $8.7M | -14.8% |
| Total Liabilities | $8.9M | -13.2% |
| Stockholders' Equity | $53.1M | -35.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.8M | +39.4% |
| Investing Cash Flow | $28.3M | -48.1% |
| Financing Cash Flow | $113K | -69.6% |